Cargando…
OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403038/ http://dx.doi.org/10.1016/S2152-2650(22)00302-0 |
| _version_ | 1784773280719175680 |
|---|---|
| author | Tahri, Sabrin de Jong, Madelon Fokkema, Cathelijne Papazian, Natalie Kellermayer, Zoltan Hollander, Chelsea Den Vermeulen, Michael van Duin, Mark van de Woestijne, Pieter Nasserinejad, Kazem Saraci, Elona D’Agostino, Mattia Gay, Francesca Van der Velden, Vincent Zweegman, Sonja van de Donk, Niels W.C.J. Broijl, Annemiek Sonneveld, Pieter Cupedo, Tom |
| author_facet | Tahri, Sabrin de Jong, Madelon Fokkema, Cathelijne Papazian, Natalie Kellermayer, Zoltan Hollander, Chelsea Den Vermeulen, Michael van Duin, Mark van de Woestijne, Pieter Nasserinejad, Kazem Saraci, Elona D’Agostino, Mattia Gay, Francesca Van der Velden, Vincent Zweegman, Sonja van de Donk, Niels W.C.J. Broijl, Annemiek Sonneveld, Pieter Cupedo, Tom |
| author_sort | Tahri, Sabrin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9403038 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94030382022-08-25 OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy Tahri, Sabrin de Jong, Madelon Fokkema, Cathelijne Papazian, Natalie Kellermayer, Zoltan Hollander, Chelsea Den Vermeulen, Michael van Duin, Mark van de Woestijne, Pieter Nasserinejad, Kazem Saraci, Elona D’Agostino, Mattia Gay, Francesca Van der Velden, Vincent Zweegman, Sonja van de Donk, Niels W.C.J. Broijl, Annemiek Sonneveld, Pieter Cupedo, Tom Clin Lymphoma Myeloma Leuk Oral Presentations Elsevier Inc. 2022-08 2022-08-25 /pmc/articles/PMC9403038/ http://dx.doi.org/10.1016/S2152-2650(22)00302-0 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Oral Presentations Tahri, Sabrin de Jong, Madelon Fokkema, Cathelijne Papazian, Natalie Kellermayer, Zoltan Hollander, Chelsea Den Vermeulen, Michael van Duin, Mark van de Woestijne, Pieter Nasserinejad, Kazem Saraci, Elona D’Agostino, Mattia Gay, Francesca Van der Velden, Vincent Zweegman, Sonja van de Donk, Niels W.C.J. Broijl, Annemiek Sonneveld, Pieter Cupedo, Tom OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| title | OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| title_full | OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| title_fullStr | OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| title_full_unstemmed | OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| title_short | OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| title_sort | oab-029: single-cell transcriptomic analysis reveals reduction of cytotoxic nk cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy |
| topic | Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403038/ http://dx.doi.org/10.1016/S2152-2650(22)00302-0 |
| work_keys_str_mv | AT tahrisabrin oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT dejongmadelon oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT fokkemacathelijne oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT papaziannatalie oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT kellermayerzoltan oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT hollanderchelseaden oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT vermeulenmichael oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT vanduinmark oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT vandewoestijnepieter oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT nasserinejadkazem oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT saracielona oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT dagostinomattia oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT gayfrancesca oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT vanderveldenvincent oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT zweegmansonja oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT vandedonknielswcj oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT broijlannemiek oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT sonneveldpieter oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy AT cupedotom oab029singlecelltranscriptomicanalysisrevealsreductionofcytotoxicnkcellsinasubsetofnewlydiagnosedmultiplemyelomapatientsimpactingoutcomeafterdaratumumabtherapy |